Browsing tag
A Johns Hopkins Children’s Center-led study in mice and lab-grown cells finds sulforaphane could help prevent and treat illnesses caused by certain coronaviruses, including COVID-19….
Italian study of long-COVID patients suggests those infected with the Alpha variant experienced different neurological and emotional symptoms compared to those who contracted the original…
Rutgers study also finds signs of emerging mutations, indicating urgent need for new drugs. An antiviral drug used to treat SARS-CoV-2 remains effective against the…
Using far-UVC light in places where people gather indoors could help prevent the next pandemic. A new type of ultraviolet light that is safe for…
Researchers have been steadily gathering important insights into the effects of COVID-19 on the body and brain. Two years into the pandemic, these findings are…
Assay can quickly and easily inform decisions about public health policy and treatment for individual patients and can rapidly detect new variants, such as omicron,…
Genetic testing of saliva samples identifies the SARS-CoV-2 virus more quickly than testing of nasal swabs. The research is published today (March 21, 2022) in…
A Phase 2 clinical trial is testing the new drug’s ability to reduce mortality in older people hospitalized with COVID-19. By directly targeting immune aging,…
Race, marital status, age, and other health issues play a major role. Black residents of Baton Rouge and New Orleans faced twice the risk of…
The protein subunit vaccine, which can be manufactured using engineered yeast, has shown promise in preclinical studies. While many people in wealthier countries have been…
Children previously infected with COVID-19 develop natural circulating antibodies that last for at least seven months, according to a new study led by researchers at…
LJI team uncovers how one odd antibody does some heavy lifting. Researchers at La Jolla Institute for Immunology (LJI) are designing better therapies for treating Ebola virus…
A small study has shown that SARS-CoV-2 vaccination in patients who had an inflamed heart muscle in the past is not associated with a recurrence…
First comprehensive trial in patients with impaired immunity shows that mRNA-based Covid-19 vaccines are well tolerated. Spare a thought for patients with impaired immunity during…
Analysis of SARS-CoV-2 reinfection risk in South Africa reveals differences among variants of concern. The Omicron variant of SARS-CoV-2 evades immunity from prior infection, an…
In humans the pandemic is showing signs of ebbing. In white-tailed deer and other wildlife, however, infections appear widespread. In 2020, Denmark culled millions of…
Tackling mental health disorders among survivors of COVID-19 should be a priority, say researchers. A study published by The BMJ recently finds that covid-19 is…
Study suggests that different modes of transmission are associated with virus evolution. Variations in virus strains in different populations are associated with varying disease severity…